Consideration of Sex Differences in Design and Reporting of Experimental Arterial Pathology Studies-Statement from ATVB Council

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 38, Issue 2, 2018, Pages 292-303

  Robinet, Peggy ^a   Milewicz, Dianna M ^b   Cassis, Lisa A ^c   Leeper, Nicholas J ^e   Lu, Hong S ^d   Smith, Jonathan D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c Department of Pharmacology and Nutritional Sciences ^*  (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

^e UNIVERSITY OF KENTUCKY   (United States)

Author keywords

animal models; aortic aneurysms; atherosclerosis; peripheral arterial disease

Indexed keywords

ABDOMINAL AORTIC ANEURYSM; AORTIC DISSECTION; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; HUMAN; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; SEX DIFFERENCE; THORACIC AORTA ANEURYSM; VASCULAR DISEASE; ANIMAL; ARTERY; CONSENSUS; DISEASE MODEL; FEMALE; MALE; MEDICAL RESEARCH; METHODOLOGY; PATHOLOGY; PROCEDURES; RISK FACTOR; SEX FACTOR; STANDARDS;

ANIMALS; ARTERIES; BIOMEDICAL RESEARCH; CONSENSUS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; PATHOLOGY; RESEARCH DESIGN; RISK FACTORS; SEX FACTORS; VASCULAR DISEASES;

EID: 85044354141     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.117.309524     Document Type: Article

References (137)

1. Mozaffarian D, Benjamin EJ, Go AS, Executive summary: heart disease and stroke statistics-2016 update: A report from the American Heart Association. Circulation 2016 133 447 454
2. Kawamoto KR, Davis MB, Duvernoy CS, Acute coronary syndromes: differences in men and women. Curr Atheroscler Rep 2016 18 73. doi: 10.1007/s11883-016-0629-7
3. Maric-Bilkan C, Arnold AP, Taylor DA, Dwinell M, Howlett SE, Wenger N, Reckelhoff JF, Sandberg K, Churchill G, Levin E, Lundberg MS, Report of the National Heart, Lung, and Blood Institute Working Group on sex differences research in cardiovascular disease: scientific questions and challenges. Hypertension 2016 67 802 807. doi: 10.1161/HYPERTENSIONAHA.115.06967
4. Miller LR, Marks C, Becker JB, Considering sex as a biological variable in preclinical research. FASEB J 2017 31 29 34. doi: 10.1096/fj.201600781R
5. Daugherty A, Hegele RA, Mackman N, Rader DJ, Schmidt AM, Weber C, Complying with the National Institutes of Health Guidelines and Principles for rigor and reproducibility: refutations. Arterioscler Thromb Vasc Biol 2016 36 1303 1304. doi: 10.1161/ATVBAHA.116.307906
6. Bentzon JF, Otsuka F, Virmani R, Falk E, Mechanisms of plaque formation and rupture. Circ Res 2014 114 1852 1866. doi: 10.1161/CIRCRESAHA.114.302721
7. Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, Liu K, Shea S, Szklo M, Bluemke DA, O'Leary DH, Tracy R, Watson K, Wong ND, Kronmal RA, Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 2008 358 1336 1345. doi: 10.1056/NEJMoa072100
8. Böhm B, Hartmann K, Buck M, Oberhoffer R, Sex differences of carotid intima-media thickness in healthy children and adolescents. Atherosclerosis 2009 206 458 463. doi: 10.1016/j.atherosclerosis.2009.03.016
9. Howard G, Sharrett AR, Heiss G, Evans GW, Chambless LE, Riley WA, Burke GL, Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators. Stroke 1993 24 1297 1304
10. Lawlor DA, Ebrahim S, Whincup P, Sterne J, Papacosta O, Wannamethee G, Dhanjil S, Griffin M, Nicolaides AN, Davey Smith G, Sex differences in body fat distribution and carotid intima media thickness: cross sectional survey using data from the British Regional Heart Study. J Epidemiol Community Health 2004 58 700 704. doi: 10.1136/jech.2003.014001
11. Mazurek K, Zmijewski P, Czajkowska A, Lutosławska G, Gender differences in carotid artery intima-media thickness and flow-mediated dilatation in young, physically active adults. J Sports Med Phys Fitness 2014 54 298 306
12. Takato T, Yamada N, Ashida T, Effects of aging and sex on progression of carotid intima-media thickness: A retrospective 6-year follow-up study. Geriatr Gerontol Int 2008 8 172 179. doi: 10.1111/j.1447-0594.2008.00467.x
13. Urbina EM, Srinivasan SR, Tang R, Bond MG, Kieltyka L, Berenson GS, Bogalusa Heart Study Impact of multiple coronary risk factors on the intima-media thickness of different segments of carotid artery in healthy young adults (The Bogalusa Heart Study). Am J Cardiol 2002 90 953 958. doi: 10.1016/S0002-9149(02)02660-7
14. Wang X, Dalmeijer GW, den Ruijter HM, Clustering of cardiovascular risk factors and carotid intima-media thickness: The USE-IMT study. PLoS One 2017 12 e0173393. doi: 10.1371/journal.pone.0173393
15. Zhao B, Liu Y, Zhang Y, Chen Y, Yang Z, Zhu Y, Zhan W, Gender difference in carotid intima-media thickness in type 2 diabetic patients: A 4-year follow-up study. Cardiovasc Diabetol 2012 11 51. doi: 10.1186/1475-2840-11-51
16. Davis E, Gorog DA, Rihal C, Prasad A, Srinivasan M, "Mind the gap" acute coronary syndrome in women: A contemporary review of current clinical evidence. Int J Cardiol 2017 227 840 849. doi: 10.1016/j.ijcard.2016.10.020
17. Anand SS, Islam S, Rosengren A, Franzosi MG, Steyn K, Yusufali AH, Keltai M, Diaz R, Rangarajan S, Yusuf S, INTERHEART Investigators Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J 2008 29 932 940. doi: 10.1093/eurheartj/ehn018
18. Dey S, Flather MD, Devlin G, Brieger D, Gurfinkel EP, Steg PG, Fitzgerald G, Jackson EA, Eagle KA, Global Registry of Acute Coronary Events Investigators Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: The Global Registry of Acute Coronary Events. Heart 2009 95 20 26. doi: 10.1136/hrt.2007.138537
19. Mnatzaganian G, Braitberg G, Hiller JE, Kuhn L, Chapman R, Sex differences in in-hospital mortality following a first acute myocardial infarction: symptomatology, delayed presentation, and hospital setting. BMC Cardiovasc Disord 2016 16 109. doi: 10.1186/s12872-016-0276-5
20. Voight BF, Peloso GM, Orho-Melander M, Plasma HDL cholesterol and risk of myocardial infarction: A Mendelian randomisation study. Lancet 2012 380 572 580. doi: 10.1016/S0140-6736(12)60312-2
21. von Eckardstein A, Rohrer L, HDLs in crises. Curr Opin Lipidol 2016 27 264 273. doi: 10.1097/MOL.0000000000000294
22. Holmes MV, Asselbergs FW, Palmer TM, UCLEB Consortium Mendelian randomization of blood lipids for coronary heart disease. Eur Heart J 2015 36 539 550. doi: 10.1093/eurheartj/eht571
23. Crosby J, Peloso GM, Auer PL, TG and HDL Working Group of the Exome Sequencing Project, National Heart, Lung, and Blood Institute Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N Engl J Med 2014 371 22 31. doi: 10.1056/NEJMoa1307095
24. Langer RD, The evidence base for HRT: what can we believe? Climacteric 2017 20 91 96. doi: 10.1080/13697137.2017.1280251
25. Robinet P, Smith JD, Wang H, Patterson C, Development and use of mouse models of atherosclerosis. In: Atherosclerosis: Risks, Mechanisms, and Therapies 2015 Hoboken, NJ John Wiley & Sons Inc 197 206
26. Getz GS, Reardon CA, Animal models of atherosclerosis. Arterioscler Thromb Vasc Biol 2012 32 1104 1115. doi: 10.1161/ATVBAHA.111.237693
27. Lee YT, Lin HY, Chan YW, Li KH, To OT, Yan BP, Liu T, Li G, Wong WT, Keung W, Tse G, Mouse models of atherosclerosis: A historical perspective and recent advances. Lipids Health Dis 2017 16 12. doi: 10.1186/s12944-016-0402-5
28. Plump AS, Smith JD, Hayek T, Aalto-Setälä K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL, Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992 71 343 353
29. Zhang SH, Reddick RL, Piedrahita JA, Maeda N, Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992 258 468 471
30. Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J, Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 1993 92 883 893. doi: 10.1172/JCI116663
31. Breslow JL, Mouse models of atherosclerosis. Science 1996 272 685-688
32. Daugherty A, Whitman SC, Quantification of atherosclerosis in mice. Methods Mol Biol 2003 209 293 309
33. Paigen B, Morrow A, Holmes PA, Mitchell D, Williams RA, Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 1987 68 231 240
34. Libby P, Lichtman AH, Hansson GK, Immune effector mechanisms implicated in atherosclerosis: from mice to humans. Immunity 2013 38 1092 1104. doi: 10.1016/j.immuni.2013.06.009
35. Libby P, Inflammation in atherosclerosis. Nature 2002 420 868 874. doi: 10.1038/nature01323
36. Ross R, Atherosclerosis-An inflammatory disease. N Engl J Med 1999 340 115 126. doi: 10.1056/NEJM199901143400207
37. Rosenfeld ME, Averill MM, Bennett BJ, Schwartz SM, Progression and disruption of advanced atherosclerotic plaques in murine models. Curr Drug Targets 2008 9 210 216
38. Bond AR, Jackson CL, The fat-fed apolipoprotein E knockout mouse brachiocephalic artery in the study of atherosclerotic plaque rupture. J Biomed Biotechnol 2011 2011 379069. doi: 10.1155/2011/379069
39. van der Heiden K, Hoogendoorn A, Daemen MJ, Gijsen FJ, Animal models for plaque rupture: A biomechanical assessment. Thromb Haemost 2016 115 501 508. doi: 10.1160/TH15-07-0614
40. Smith JD, James D, Dansky HM, Wittkowski KM, Moore KJ, Breslow JL, In silico quantitative trait locus map for atherosclerosis susceptibility in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2003 23 117 122
41. Teupser D, Persky AD, Breslow JL, Induction of atherosclerosis by low-fat, semisynthetic diets in LDL receptor-deficient C57BL/6J and FVB/NJ mice: comparison of lesions of the aortic root, brachiocephalic artery, and whole aorta (en face measurement). Arterioscler Thromb Vasc Biol 2003 23 1907 1913. doi: 10.1161/01.ATV.0000090126.34881.B1
42. Teupser D, Pavlides S, Tan M, Gutierrez-Ramos JC, Kolbeck R, Breslow JL, Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root. Proc Natl Acad Sci USA 2004 101 17795 17800. doi: 10.1073/pnas.0408096101
43. Surra JC, Guillén N, Arbonés-Mainar JM, Barranquero C, Navarro MA, Arnal C, Orman I, Segovia JC, Osada J, Sex as a profound modifier of atherosclerotic lesion development in apolipoprotein E-deficient mice with different genetic backgrounds. J Atheroscler Thromb 2010 17 712 721
44. Grimsditch DC, Penfold S, Latcham J, Vidgeon-Hart M, Groot PH, Benson GM, C3H apoE(-/-) mice have less atherosclerosis than C57BL apoE(-/-) mice despite having a more atherogenic serum lipid profile. Atherosclerosis 2000 151 389 397
45. Caligiuri G, Nicoletti A, Zhou X, Törnberg I, Hansson GK, Effects of sex and age on atherosclerosis and autoimmunity in apoE-deficient mice. Atherosclerosis 1999 145 301 308
46. Maeda N, Johnson L, Kim S, Hagaman J, Friedman M, Reddick R, Anatomical differences and atherosclerosis in apolipoprotein E-deficient mice with 129/SvEv and C57BL/6 genetic backgrounds. Atherosclerosis 2007 195 75 82. doi: 10.1016/j.atherosclerosis.2006.12.006
47. Pereira TM, Nogueira BV, Lima LC, Porto ML, Arruda JA, Vasquez EC, Meyrelles SS, Cardiac and vascular changes in elderly atherosclerotic mice: The influence of gender. Lipids Health Dis 2010 9 87. doi: 10.1186/1476-511X-9-87
48. Dansky HM, Charlton SA, Sikes JL, Heath SC, Simantov R, Levin LF, Shu P, Moore KJ, Breslow JL, Smith JD, Genetic background determines the extent of atherosclerosis in apoE-deficient mice. Arterioscler Thromb Vasc Biol 1999 19 1960 1968
49. Bennett BJ, Davis RC, Civelek M, Genetic architecture of atherosclerosis in mice: A systems genetics analysis of common inbred strains. PLoS Genet 2015 11 e1005711. doi: 10.1371/journal.pgen.1005711
50. Chiba T, Ikeda M, Umegaki K, Tomita T, Estrogen-dependent activation of neutral cholesterol ester hydrolase underlying gender difference of atherogenesis in apoE-/-mice. Atherosclerosis 2011 219 545 551. doi: 10.1016/j.atherosclerosis.2011.08.051
51. Smith DD, Tan X, Tawfik O, Milne G, Stechschulte DJ, Dileepan KN, Increased aortic atherosclerotic plaque development in female apolipoprotein E-null mice is associated with elevated thromboxane A2 and decreased prostacyclin production. J Physiol Pharmacol 2010 61 309 316
52. Tangirala RK, Rubin EM, Palinski W, Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J Lipid Res 1995 36 2320 2328
53. Li AC, Brown KK, Silvestre MJ, Willson TM, Palinski W, Glass CK, Peroxisome proliferator-Activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J Clin Invest 2000 106 523 531. doi: 10.1172/JCI10370
54. Whitman SC, Ravisankar P, Daugherty A, IFN-gamma deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E-/-mice. J Interferon Cytokine Res 2002 22 661 670. doi: 10.1089/10799900260100141
55. Wang SS, Schadt EE, Wang H, Wang X, Ingram-Drake L, Shi W, Drake TA, Lusis AJ, Identification of pathways for atherosclerosis in mice: integration of quantitative trait locus analysis and global gene expression data. Circ Res 2007 101 e11 e30. doi: 10.1161/CIRCRESAHA.107.152975
56. Bhasin JM, Chakrabarti E, Peng DQ, Kulkarni A, Chen X, Smith JD, Sex specific gene regulation and expression QTLs in mouse macrophages from a strain intercross. PLoS One 2008 3 e1435. doi: 10.1371/journal.pone.0001435
57. Daugherty A, Tall AR, Daemen MJAP, Falk E, Fisher EA, García-Cardeña G, Lusis AJ, Owens AP III, Rosenfeld ME, Virmani R, American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Basic Cardiovascular Sciences Recommendation on design, execution, and reporting of animal atherosclerosis studies: A scientific statement from the American Heart Association. Arterioscler Thromb Vasc Biol 2017 37 e131 e157. doi: 10.1161/ATV.0000000000000062
58. Hiratzka LF, Bakris GL, Beckman JA, American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery; American College of Radiology; American Stroke Association; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society of Interventional Radiology; Society of Thoracic Surgeons; Society for Vascular Medicine 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 2010 121 e266 e369. doi: 10.1161/CIR.0b013e3181d4739e
59. Hoyert DL, Arias E, Smith BL, Murphy SL, Kochanek KD, Deaths: final data for 1999. Natl Vital Stat Rep 2001 49 1 113
60. Pape LA, Tsai TT, Isselbacher EM, Aortic diameter >or = 5.5 cm is not a good predictor of type A aortic dissection: observations from the International Registry of Acute Aortic Dissection (IRAD). Circulation 2007 116 1120 1127
61. Détaint D, Faivre L, Collod-Beroud G, Cardiovascular manifestations in men and women carrying a FBN1 mutation. Eur Heart J 2010 31 2223 2229. doi: 10.1093/eurheartj/ehq258
62. Roman MJ, Rosen SE, Kramer-Fox R, Devereux RB, Prognostic significance of the pattern of aortic root dilation in the Marfan syndrome. J Am Coll Cardiol 1993 22 1470 1476
63. Groth KA, Stochholm K, Hove H, Kyhl K, Gregersen PA, Vejlstrup N, Østergaard JR, Gravholt CH, Andersen NH, Aortic events in a nationwide Marfan syndrome cohort. Clin Res Cardiol 2017 106 105 112. doi: 10.1007/s00392-016-1028-3
64. Roman MJ, Devereux RB, Preiss LR, GenTAC Investigators Associations of age and sex with Marfan phenotype: The National Heart, Lung, and Blood Institute GenTAC (Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions) Registry. Circ Cardiovasc Genet 2017 10 e001647. doi: 10.1161/CIRCGENETICS.116.001647
65. Jondeau G, Ropers J, Regalado E, Montalcino Aortic Consortium International Registry of Patients Carrying TGFBR1 or TGFBR2 Mutations: results of the MAC (Montalcino Aortic Consortium). Circ Cardiovasc Genet 2016 9 548 558. doi: 10.1161/CIRCGENETICS.116.001485
66. Regalado ES, Guo DC, Prakash S, Montalcino Aortic Consortium Aortic disease presentation and outcome associated with ACTA2 mutations. Circ Cardiovasc Genet 2015 8 457 464. doi: 10.1161/CIRCGENETICS.114.000943
67. Carlson M, Airhart N, Lopez L, Silberbach M, Moderate aortic enlargement and bicuspid aortic valve are associated with aortic dissection in Turner syndrome: report of the international turner syndrome aortic dissection registry. Circulation 2012 126 2220 2226. doi: 10.1161/CIRCULATIONAHA.111.088633
68. LeMaire SA, McDonald ML, Guo DC, Genome-wide association study identifies a susceptibility locus for thoracic aortic aneurysms and aortic dissections spanning FBN1 at 15q21.1. Nat Genet 2011 43 996 1000. doi: 10.1038/ng.934
69. Hagan PG, Nienaber CA, Isselbacher EM, The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA 2000 283 897 903
70. Nienaber CA, Fattori R, Mehta RH, International Registry of Acute Aortic Dissection Gender-related differences in acute aortic dissection. Circulation 2004 109 3014 3021. doi: 10.1161/01.CIR.0000130644.78677.2C
71. Liang NL, Genovese EA, Al-Khoury GE, Hager ES, Makaroun MS, Singh MJ, Effects of gender differences on short-Term outcomes in patients with type B aortic dissection. Ann Vasc Surg 2017 38 78 83. doi: 10.1016/j.avsg.2016.06.006
72. Deery SE, Shean KE, Wang GJ, Black JH III, Upchurch GR Jr, Giles KA, Patel VI, Schermerhorn ML, Society for Vascular Surgery Vascular Quality Initiative Female sex independently predicts mortality after thoracic endovascular aortic repair for intact descending thoracic aortic aneurysms. J Vasc Surg 2017 66 2 8. doi: 10.1016/j.jvs.2016.12.103
73. Habashi JP, Judge DP, Holm TM, Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 2006 312 117 121. doi: 10.1126/science.1124287
74. Cook JR, Clayton NP, Carta L, Galatioto J, Chiu E, Smaldone S, Nelson CA, Cheng SH, Wentworth BM, Ramirez F, Dimorphic effects of transforming growth factor-β signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome. Arterioscler Thromb Vasc Biol 2015 35 911 917. doi: 10.1161/ATVBAHA.114.305150
75. Pereira L, Lee SY, Gayraud B, Andrikopoulos K, Shapiro SD, Bunton T, Biery NJ, Dietz HC, Sakai LY, Ramirez F, Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. Proc Natl Acad Sci USA 1999 96 3819 3823
76. Pereira L, Andrikopoulos K, Tian J, Lee SY, Keene DR, Ono R, Reinhardt DP, Sakai LY, Biery NJ, Bunton T, Dietz HC, Ramirez F, Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome. Nat Genet 1997 17 218 222. doi: 10.1038/ng1097-218
77. Gallo EM, Loch DC, Habashi JP, Angiotensin II-dependent TGF-β signaling contributes to Loeys-Dietz syndrome vascular pathogenesis. J Clin Invest 2014 124 448 460. doi: 10.1172/JCI69666
78. Huang J, Davis EC, Chapman SL, Budatha M, Marmorstein LY, Word RA, Yanagisawa H, Fibulin-4 deficiency results in ascending aortic aneurysms: A potential link between abnormal smooth muscle cell phenotype and aneurysm progression. Circ Res 2010 106 583 592. doi: 10.1161/CIRCRESAHA.109.207852
79. Kuang SQ, Medina-Martinez O, Guo DC, FOXE3 mutations predispose to thoracic aortic aneurysms and dissections. J Clin Invest 2016 126 948 961. doi: 10.1172/JCI83778
80. Li W, Li Q, Jiao Y, Qin L, Ali R, Zhou J, Ferruzzi J, Kim RW, Geirsson A, Dietz HC, Offermanns S, Humphrey JD, Tellides G, Tgfbr2 disruption in postnatal smooth muscle impairs aortic wall homeostasis. J Clin Invest 2014 124 755 767. doi: 10.1172/JCI69942
81. Kuang SQ, Geng L, Prakash SK, Cao JM, Guo S, Villamizar C, Kwartler CS, Peters AM, Brasier AR, Milewicz DM, Aortic remodeling after transverse aortic constriction in mice is attenuated with AT1 receptor blockade. Arterioscler Thromb Vasc Biol 2013 33 2172 2179. doi: 10.1161/ATVBAHA.113.301624
82. Johnston KW, Rutherford RB, Tilson MD, Shah DM, Hollier L, Stanley JC, Suggested standards for reporting on arterial aneurysms. Subcommittee on Reporting Standards for Arterial Aneurysms, Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery. J Vasc Surg 1991 13 452 458
83. Gorham TJ, Taylor J, Raptis S, Endovascular treatment of abdominal aortic aneurysm. Br J Surg 2004 91 815 827. doi: 10.1002/bjs.4611
84. Kent KC, Zwolak RM, Egorova NN, Riles TS, Manganaro A, Moskowitz AJ, Gelijns AC, Greco G, Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals. J Vasc Surg 2010 52 539 548. doi: 10.1016/j.jvs.2010.05.090
85. Sakalihasan N, Limet R, Defawe OD, Abdominal aortic aneurysm. Lancet 2005 365 1577 1589. doi: 10.1016/S0140-6736(05)66459-8
86. Lederle FA, Johnson GR, Wilson SE, Aneurysm Detection and Management Veterans Affairs Cooperative Study Abdominal aortic aneurysm in women. J Vasc Surg 2001 34 122 126. doi: 10.1067/mva.2001.115275
87. LeFevre ML, U.S. Preventive Services Task Force Screening for abdominal aortic aneurysm: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014 161 281 290. doi: 10.7326/M14-1204
88. Schermerhorn ML, O'Malley AJ, Landon BE, Long-Term outcomes of abdominal aortic aneurysm repair. N Engl J Med 2015 373 2088 2089. doi: 10.1056/NEJMc1511634
89. Forsdahl SH, Singh K, Solberg S, Jacobsen BK, Risk factors for abdominal aortic aneurysms: A 7-year prospective study: The Tromsø study, 1994-2001. Circulation 2009 119 2202 2208. doi: 10.1161/CIRCULATIONAHA.108.817619
90. Katz DJ, Stanley JC, Zelenock GB, Gender differences in abdominal aortic aneurysm prevalence, treatment, and outcome. J Vasc Surg 1997 25 561 568
91. Lo RC, Schermerhorn ML, Abdominal aortic aneurysms in women. J Vasc Surg 2016 63 839 844. doi: 10.1016/j.jvs.2015.10.087
92. Lo RC, Bensley RP, Dahlberg SE, Matyal R, Hamdan AD, Wyers M, Chaikof EL, Schermerhorn ML, Presentation, treatment, and outcome differences between men and women undergoing revascularization or amputation for lower extremity peripheral arterial disease. J Vasc Surg 2014 59 409 418. e3
93. Desai M, Choke E, Sayers RD, Nath M, Bown MJ, Sex-related trends in mortality after elective abdominal aortic aneurysm surgery between 2002 and 2013 at National Health Service hospitals in England: less benefit for women compared with men. Eur Heart J 2016 37 3452 3460. doi: 10.1093/eurheartj/ehw335
94. Mofidi R, Goldie VJ, Kelman J, Dawson AR, Murie JA, Chalmers RT, Influence of sex on expansion rate of abdominal aortic aneurysms. Br J Surg 2007 94 310 314. doi: 10.1002/bjs.5573
95. Lo RC, Bensley RP, Hamdan AD, Wyers M, Adams JE, Schermerhorn ML, Vascular Study Group of New England Gender differences in abdominal aortic aneurysm presentation, repair, and mortality in the Vascular Study Group of New England. J Vasc Surg 2013 57 1261 1268, 1268.e1 5. doi: 10.1016/j.jvs.2012.11.039
96. Egorova NN, Vouyouka AG, McKinsey JF, Faries PL, Kent KC, Moskowitz AJ, Gelijns A, Effect of gender on long-Term survival after abdominal aortic aneurysm repair based on results from the Medicare national database. J Vasc Surg 2011 54 1 12.e6. discussion 11. doi: 10.1016/j.jvs.2010.12.049
97. Alcorn HG, Wolfson SK Jr, Sutton-Tyrrell K, Kuller LH, O'Leary D, Risk factors for abdominal aortic aneurysms in older adults enrolled in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1996 16 963 970
98. Ninomiya OH, Tavares Monteiro JA, Higuchi Mde L, Puech-Leão P, de Luccia N, Raghavan ML, da Silva ES, Biomechanical properties and microstructural analysis of the human nonaneurysmal aorta as a function of age, gender and location: An Autopsy study. J Vasc Res 2015 52 257 264. doi: 10.1159/000442979
99. Larsson E, Labruto F, Gasser TC, Swedenborg J, Hultgren R, Analysis of aortic wall stress and rupture risk in patients with abdominal aortic aneurysm with a gender perspective. J Vasc Surg 2011 54 295 299. doi: 10.1016/j.jvs.2010.12.053
100. Daugherty A, Cassis L, Chronic angiotensin II infusion promotes atherogenesis in low density lipoprotein receptor-/-mice. Ann N Y Acad Sci 1999 892 108 118
101. Daugherty A, Manning MW, Cassis LA, Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 2000 105 1605 1612. doi: 10.1172/JCI7818
102. Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT, Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 2002 110 625 632. doi: 10.1172/JCI15334
103. Pyo R, Lee JK, Shipley JM, Curci JA, Mao D, Ziporin SJ, Ennis TL, Shapiro SD, Senior RM, Thompson RW, Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 2000 105 1641 1649. doi: 10.1172/JCI8931
104. Ailawadi G, Eliason JL, Roelofs KJ, Sinha I, Hannawa KK, Kaldjian EP, Lu G, Henke PK, Stanley JC, Weiss SJ, Thompson RW, Upchurch GR Jr., Gender differences in experimental aortic aneurysm formation. Arterioscler Thromb Vasc Biol 2004 24 2116 2122. doi: 10.1161/01.ATV.0000143386.26399.84
105. Lu H, Howatt DA, Balakrishnan A, Moorleghen JJ, Rateri DL, Cassis LA, Daugherty A, Subcutaneous angiotensin II infusion using osmotic pumps induces aortic aneurysms in mice. J Vis Exp 2015 103. doi: 10.3791/53191
106. Laser A, Ghosh A, Roelofs K, Sadiq O, McEvoy B, DiMusto P, Eliason J, Upchurch GR Jr., Increased estrogen receptor alpha in experimental aortic aneurysms in females compared with males. J Surg Res 2014 186 467 474. doi: 10.1016/j.jss.2013.07.050
107. Johnston WF, Salmon M, Su G, Lu G, Ailawadi G, Upchurch GR Jr., Aromatase is required for female abdominal aortic aneurysm protection. J Vasc Surg 2015 61 1565 1574.e1. doi: 10.1016/j.jvs.2014.01.032
108. Davis JP, Salmon M, Pope NH, Lu G, Su G, Sharma AK, Ailawadi G, Upchurch GR Jr., Attenuation of aortic aneurysms with stem cells from different genders. J Surg Res 2015 199 249 258. doi: 10.1016/j.jss.2015.04.025
109. Henriques TA, Huang J, D'Souza SS, Daugherty A, Cassis LA, Orchidectomy, but not ovariectomy, regulates angiotensin II-induced vascular diseases in apolipoprotein E-deficient mice. Endocrinology 2004 145 3866 3872. doi: 10.1210/en.2003-1615
110. Henriques T, Zhang X, Yiannikouris FB, Daugherty A, Cassis LA, Androgen increases AT1a receptor expression in abdominal aortas to promote angiotensin II-induced AAAs in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2008 28 1251 1256. doi: 10.1161/ATVBAHA.107.160382
111. Zhang X, Thatcher SE, Rateri DL, Bruemmer D, Charnigo R, Daugherty A, Cassis LA, Transient exposure of neonatal female mice to testosterone abrogates the sexual dimorphism of abdominal aortic aneurysms. Circ Res 2012 110 e73 e85. doi: 10.1161/CIRCRESAHA.111.253880
112. Thatcher SE, Zhang X, Woody S, Wang Y, Alsiraj Y, Charnigo R, Daugherty A, Cassis LA, Exogenous 17-β estradiol administration blunts progression of established angiotensin II-induced abdominal aortic aneurysms in female ovariectomized mice. Biol Sex Differ 2015 6 12. doi: 10.1186/s13293-015-0030-1
113. Alsiraj Y, Thatcher SE, Charnigo R, Chen K, Blalock E, Daugherty A, Cassis LA, Female mice with an XY sex chromosome complement develop severe angiotensin II-induced abdominal aortic aneurysms. Circulation 2017 135 379 391. doi: 10.1161/CIRCULATIONAHA.116.023789
114. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR, Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001 286 1317 1324
115. Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, Norman PE, Sampson UK, Williams LJ, Mensah GA, Criqui MH, Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: A systematic review and analysis. Lancet 2013 382 1329 1340. doi: 10.1016/S0140-6736(13)61249-0
116. Kullo IJ, Leeper NJ, The genetic basis of peripheral arterial disease: current knowledge, challenges, and future directions. Circ Res 2015 116 1551 1560. doi: 10.1161/CIRCRESAHA.116.303518
117. Teodorescu VJ, Vavra AK, Kibbe MR, Peripheral arterial disease in women. J Vasc Surg 2013 57 suppl 4 18S 26S. doi: 10.1016/j.jvs.2012.10.115
118. Criqui MH, Aboyans V, Epidemiology of peripheral artery disease. Circ Res 2015 116 1509 1526. doi: 10.1161/CIRCRESAHA.116.303849
119. Nead KT, Cooke JP, Olin JW, Leeper NJ, Alternative ankle-brachial index method identifies additional at-risk individuals. J Am Coll Cardiol 2013 62 553 559. doi: 10.1016/j.jacc.2013.04.061
120. McDermott MM, Greenland P, Liu K, Criqui MH, Guralnik JM, Celic L, Chan C, Sex differences in peripheral arterial disease: leg symptoms and physical functioning. J Am Geriatr Soc 2003 51 222 228
121. Chang P, Nead KT, Olin JW, Cooke JP, Leeper NJ, Clinical and socioeconomic factors associated with unrecognized peripheral artery disease. Vasc Med 2014 19 289 296. doi: 10.1177/1358863X14535475
122. Hirsch AT, Allison MA, Gomes AS, Corriere MA, Duval S, Ershow AG, Hiatt WR, Karas RH, Lovell MB, McDermott MM, Mendes DM, Nussmeier NA, Treat-Jacobson D, American Heart Association Council on Peripheral Vascular Disease; Council on Cardiovascular Nursing; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Surgery and Anesthesia; Council on Clinical Cardiology; Council on Epidemiology and Prevention A call to action: women and peripheral artery disease: A scientific statement from the American Heart Association. Circulation 2012 125 1449 1472. doi: 10.1161/CIR.0b013e31824c39ba
123. Oka RK, Szuba A, Giacomini JC, Cooke JP, Gender differences in perception of PAD: A pilot study. Vasc Med 2003 8 89 94. doi: 10.1191/1358863x03vm479oa
124. Cacoub PP, Abola MT, Baumgartner I, Bhatt DL, Creager MA, Liau CS, Goto S, Röther J, Steg PG, Hirsch AT, REACH Registry Investigators Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Atherosclerosis 2009 204 e86 e92. doi: 10.1016/j.atherosclerosis.2008.10.023
125. Perin EC, Murphy MP, March KL, Cardiovascular Cell Therapy Research Network (CCTRN) Evaluation of cell therapy on exercise performance and limb perfusion in peripheral artery disease: The CCTRN PACE Trial (Patients With Intermittent Claudication Injected With ALDH Bright Cells). Circulation 2017 135 1417 1428. doi: 10.1161/CIRCULATIONAHA.116.025707
126. Feinglass J, McDermott MM, Foroohar M, Pearce WH, Gender differences in interventional management of peripheral vascular disease: evidence from a blood flow laboratory population. Ann Vasc Surg 1994 8 343 349. doi: 10.1007/BF02132995
127. Ferranti KM, Osler TM, Duffy RP, Stanley AC, Bertges DJ, Vascular Study Group of New England Association between gender and outcomes of lower extremity peripheral vascular interventions. J Vasc Surg 2015 62 990 997. doi: 10.1016/j.jvs.2015.03.066
128. Westendorp IC, in't Veld BA, Grobbee DE, Pols HA, Meijer WT, Hofman A, Witteman JC, Hormone replacement therapy and peripheral arterial disease: The Rotterdam study. Arch Intern Med 2000 160 2498 2502
129. Hsia J, Simon JA, Lin F, Applegate WB, Vogt MT, Hunninghake D, Carr M, Peripheral arterial disease in randomized trial of estrogen with progestin in women with coronary heart disease: The Heart and Estrogen/Progestin Replacement Study. Circulation 2000 102 2228 2232
130. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J, Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002 288 321 333. doi: 10.1001/jama.288.3.321
131. Hsia J, Criqui MH, Herrington DM, Manson JE, Wu L, Heckbert SR, Allison M, McDermott MM, Robinson J, Masaki K, Women's Health Initiative Research Group Conjugated equine estrogens and peripheral arterial disease risk: The Women's Health Initiative. Am Heart J 2006 152 170 176. doi: 10.1016/j.ahj.2005.09.005
132. Lotfi S, Patel AS, Mattock K, Egginton S, Smith A, Modarai B, Towards a more relevant hind limb model of muscle ischaemia. Atherosclerosis 2013 227 1 8. doi: 10.1016/j.atherosclerosis.2012.10.060
133. Niiyama H, Huang NF, Rollins MD, Cooke JP, Murine model of hindlimb ischemia. J Vis Exp 2009 1035. doi: 10.3791/1035
134. Nanda V, Downing KP, Ye J, CDKN2B regulates TGFβ signaling and smooth muscle cell investment of hypoxic neovessels. Circ Res 2016 118 230 240. doi: 10.1161/CIRCRESAHA.115.307906
135. Dokun AO, Keum S, Hazarika S, Li Y, Lamonte GM, Wheeler F, Marchuk DA, Annex BH, A quantitative trait locus (LSq-1) on mouse chromosome 7 is linked to the absence of tissue loss after surgical hindlimb ischemia. Circulation 2008 117 1207 1215. doi: 10.1161/CIRCULATIONAHA.107.736447
136. Peng X, Wang J, Lassance-Soares RM, Najafi AH, Sood S, Aghili N, Alderman LO, Panza JA, Faber JE, Wang S, Epstein SE, Burnett MS, Gender differences affect blood flow recovery in a mouse model of hindlimb ischemia. Am J Physiol Heart Circ Physiol 2011 300 H2027 H2034. doi: 10.1152/ajpheart.00004.2011
137. Sieveking DP, Lim P, Chow RW, Dunn LL, Bao S, McGrath KC, Heather AK, Handelsman DJ, Celermajer DS, Ng MK, A sex-specific role for androgens in angiogenesis. J Exp Med 2010 207 345 352. doi: 10.1084/jem.20091924.